iANTHUS CAPITAL HOLDINGS (ITHUF) Total Current Liabilities (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Total Current Liabilities came in at $71.9 million in Q1 2026, down 7.65% year-on-year from $77.8 million in Q1 2025, and up 4.91% quarter-over-quarter from $68.5 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Total Current Liabilities (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Total Current Liabilities across 7 years of filings, most recently posting $71.9 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $71.9 million, down 7.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $71.9 million (down 7.65% YoY), and the FY2025 annual result was $68.5 million, down 9.01% from the prior year.
- Total Current Liabilities came in at $71.9 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $68.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $314.6 million in Q1 2022 to a low of $68.5 million in Q4 2025.
- The 5-year median for Total Current Liabilities is $104.3 million (2022), against an average of $111.4 million.
- Across the five-year window, Total Current Liabilities plunged 67.56% in 2022 and soared 35.5% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Total Current Liabilities stood at $92.6 million in 2022, then jumped by 35.5% to $125.4 million in 2023, then slumped by 39.97% to $75.3 million in 2024, then fell by 9.01% to $68.5 million in 2025, then advanced by 4.91% to $71.9 million in 2026.
- The last three Total Current Liabilities figures came in at $71.9 million (Q1 2026), $68.5 million (Q4 2025), and $70.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 71.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.88 Mn |
| Dec 31, 2025 | 68.51 Mn |
| Sep 30, 2025 | 70.57 Mn |
| Jun 30, 2025 | 79.17 Mn |
| Mar 31, 2025 | 77.83 Mn |
| Dec 31, 2024 | 75.29 Mn |
| Sep 30, 2024 | 86.06 Mn |
| Jun 30, 2024 | 119.47 Mn |
| Mar 31, 2024 | 128.66 Mn |
| Dec 31, 2023 | 125.43 Mn |
| Sep 30, 2023 | 133.30 Mn |
| Jun 30, 2023 | 125.53 Mn |
| Mar 31, 2023 | 114.26 Mn |
| Dec 31, 2022 | 92.57 Mn |
| Sep 30, 2022 | 104.28 Mn |
| Jun 30, 2022 | 106.99 Mn |
| Mar 31, 2022 | 314.57 Mn |
| Dec 31, 2021 | 285.31 Mn |
| Sep 30, 2021 | 275.08 Mn |
| Jun 30, 2021 | 261.62 Mn |